Free Trial

Apogee Therapeutics (APGE) SEC Filings & 10K Form

Apogee Therapeutics logo
$40.48 +1.29 (+3.28%)
As of 01:06 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Apogee Therapeutics SEC Filings

DateFilerForm TypeView
04/29/2025
3:15 PM
Apogee Therapeutics (Filer)
Form DEF 14A
04/04/2025
7:01 PM
Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
5:30 AM
Apogee Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2025
7:01 PM
Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
7:02 PM
Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
12:46 PM
Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
6:06 AM
Apogee Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/03/2025
6:12 AM
Apogee Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2025
5:30 AM
Apogee Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2025
8:00 AM
Apogee Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SCHEDULE 13G
02/07/2025
7:01 PM
Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
7:02 PM
Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
1:02 PM
Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
6:05 AM
Apogee Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2025
7:00 PM
Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
7:00 PM
Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
11:23 AM
Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/03/2025
7:00 PM
Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
5:00 AM
Apogee Therapeutics (Issuer)
McKenna Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
7:01 PM
Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
7:01 PM
Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
7:02 PM
Apogee Therapeutics (Issuer)
Henderson Jane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
7:02 PM
Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
3:59 PM
Apogee Therapeutics (Subject)
Dambkowski Carl (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/10/2024
6:30 AM
Apogee Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2024
7:01 PM
Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
7:02 PM
Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2024
10:12 AM
Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2024
5:17 AM
Apogee Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
4:46 PM
Apogee Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G/A
11/14/2024
10:16 AM
Apogee Therapeutics (Subject)
DRIEHAUS CAPITAL MANAGEMENT LLC (Filed by)
Form SC 13G
11/14/2024
9:18 AM
Apogee Therapeutics (Subject)
Deep Track Capital, LP (Filed by)
Form SC 13G/A
11/12/2024
6:15 AM
Apogee Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2024
6:05 AM
Apogee Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
7:01 PM
Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
7:02 PM
Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
10:39 AM
Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/04/2024
6:59 PM
ACCESS INDUSTRIES MANAGEMENT, LLC (Filed by)
Apogee Therapeutics (Subject)
Form SC 13G/A
10/24/2024
7:10 AM
Apogee Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
5:06 PM
Apogee Therapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G
10/04/2024
7:01 PM
Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Elon Reveals Why There Soon Won’t Be Any Money For Social Security (Ad)

Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a terrifying supercar crash with billionaire Peter Thiel, then from a deadly strain of malaria—Elon Musk emerged with a stark warning for Americans about looming financial dangers. Discover the little-known Trump IRS loophole that thousands are now using to safeguard their retirement from inflation and market turmoil—before it's too late.

See why thousands of forward-thinking retirement savers are now requesting this FREE 2025 Wealth Pro
10/04/2024
7:02 PM
Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
9:05 AM
Apogee Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
10/02/2024
3:20 PM
Apogee Therapeutics (Subject)
Dambkowski Carl (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2024
1:34 PM
Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/06/2024
7:02 PM
Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2024
7:03 PM
Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
12:35 PM
Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/23/2024
7:05 PM
Apogee Therapeutics (Issuer)
Henderson Jane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
6:29 AM
Apogee Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
4:25 PM
Apogee Therapeutics (Filer)
Form S-3ASR
08/12/2024
6:00 AM
Apogee Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2024
5:35 AM
Apogee Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
7:05 PM
Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2024
7:05 PM
Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
12:18 PM
Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/05/2024
7:01 PM
Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2024
7:01 PM
Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2024
12:39 PM
Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/03/2024
12:13 PM
Apogee Therapeutics (Subject)
Dambkowski Carl (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2024
7:12 PM
Apogee Therapeutics (Issuer)
JONES WILLIAM A JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
7:00 PM
Apogee Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
7:01 PM
Apogee Therapeutics (Issuer)
Gottesdiener Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
7:02 PM
Apogee Therapeutics (Issuer)
Shah Nimish P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
7:03 PM
Apogee Therapeutics (Issuer)
Fox Jennifer A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
7:04 PM
Apogee Therapeutics (Issuer)
Bollinger Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
7:05 PM
Apogee Therapeutics (Issuer)
McKenna Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
7:05 PM
Apogee Therapeutics (Issuer)
Bollinger Lisa (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/30/2024
7:07 PM
Apogee Therapeutics (Issuer)
Bollinger Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
6:35 AM
Apogee Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2024
6:36 AM
Apogee Therapeutics (Filer)
Form DEFA14A
05/15/2024
3:39 PM
Apogee Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
6:10 AM
Apogee Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2024
6:26 AM
Apogee Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/13/2024
6:05 AM
Apogee Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:APGE) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners